Skip to main content

Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis

Publication: Journal of Clinical Oncology
PDF

Abstract

Purpose

Dietary fat may play a role in lung carcinogenesis. Findings from epidemiologic studies, however, remain inconsistent. In this pooled analysis of 10 prospective cohort studies from the United States, Europe, and Asia, we evaluated the associations of total and specific types of dietary fat with lung cancer risk.

Methods

Cox regression was used to estimate hazard ratios (HRs) and 95% CIs in each cohort. Study-specific risk estimates were pooled by random- or fixed-effects meta-analysis. The first 2 years of follow-up were excluded to address potential influence of preclinical dietary changes.

Results

Among 1,445,850 participants, 18,822 incident cases were identified (mean follow-up, 9.4 years). High intakes of total and saturated fat were associated with an increased risk of lung cancer (for highest v lowest quintile: HR, 1.07 and 1.14, respectively; 95% CI, 1.00 to 1.15 and 1.07 to 1.22, respectively; P for trend for both < .001). The positive association of saturated fat was more evident among current smokers (HR, 1.23; 95% CI, 1.13 to 1.35; P for trend < .001) than former/never smokers (P for interaction = .004), and for squamous cell and small cell carcinoma (HR, 1.61 and 1.40, respectively; 95% CI, 1.38 to 1.88 and 1.17 to 1.67, respectively; P for trend for both < .001) than other histologic types (P for heterogeneity < .001). In contrast, a high intake of polyunsaturated fat was associated with a decreased risk of lung cancer (HR, 0.92; 95% CI, 0.87 to 0.98 for highest v lowest quintile; P for trend = .02). A 5% energy substitution of saturated fat with polyunsaturated fat was associated with a 16% to 17% lower risk of small cell and squamous cell carcinoma. No associations were found for monounsaturated fat.

Conclusion

Findings from this large, international cohort consortium suggest that modifying dietary fat intake (ie, replacing saturated fat with polyunsaturated fat) may reduce lung cancer risk, particularly among smokers and for squamous cell and small cell carcinoma.

Introduction

Lung cancer, the most common cancer in the world, accounts for about 13% of total cancer cases and 20% of cancer-related deaths worldwide annually.1 Although the vast majority of lung cancer is explained by tobacco smoking,2 dietary factors have also been suggested to influence lung cancer risk.3 The World Cancer Research Fund/American Institute for Cancer Research considers fruit and other foods containing carotenoids as probable protective factors,4,5 whereas red or processed meat, total fat, and butter have been suggested as possible risk factors.4 Emerging evidence further indicates that specific types of fat (ie, saturated, monounsaturated, and polyunsaturated fat) may play different roles in lung carcinogenesis.6 Findings from epidemiologic studies, however, remain inconsistent. Several case-control studies reported that saturated fat was associated with a higher risk for lung cancer in men and in nonsmoking, white women.7-10 A few prospective cohort studies also found a positive association with saturated fat among men, especially heavy smokers11,12; however, other cohort studies observed no association.13-15 Evidence linking mono- or polyunsaturated fat with lung cancer is also inconsistent. Some case-control studies8,10 and prospective studies11,13 suggested that total unsaturated or monounsaturated fat is positively associated with lung cancer risk among men. In contrast, a significantly lower risk of lung cancer was linked with higher consumptions of plant-based fat (mostly unsaturated fat)15 and fish (a source of polyunsaturated fat).16 Overall, evidence from prospective cohort studies and meta-analyses is elusive regarding the association of specific types of dietary fat with lung cancer.11,13-15,17
In this study, we investigated the association between dietary fat intake and the risk of lung cancer, using data pooled from 10 prospective cohort studies in the United States, Europe, and Asia. We evaluated the associations between total and specific types of dietary fat intakes and lung cancer risk overall, and by smoking status, sex, race/ethnicity, and histologic type.

Methods

Study Populations

This analysis includes individual-level data from 10 prospective cohorts: the National Institutes of Health-AARP Study,18 Health Professionals’ Follow-up Study,19 Iowa Women’s Health Study,20 Nurses’ Health Study,21 Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial,22 Southern Community Cohort Study,23 Vitamins and Lifestyle Study,24 European Prospective Investigation into Cancer & Nutrition,25 Shanghai Men’s Health Study,26 and Shanghai Women’s Health Study.27 All studies were approved by institutional review boards at local institutions. The current study only involved analyzing de-identified information.
In each study, we excluded participants who had a history of any cancer except nonmelanoma skin cancer, who did not report smoking status, and who reported implausible energy intake. Implausible energy intake was determined by predefined ranges in five cohorts (Health Professionals’ Follow-up Study, Iowa Women’s Health Study, Nurses’ Health Study, Southern Community Cohort Study, and Vitamins and Lifestyle Study) or by cohort- and sex-specific ranges (beyond three standard deviations of the log-transformed mean energy intake). To minimize potential influence due to preclinical diseases and/or dietary changes, we also excluded the first 2 years of follow-up, including participants who died, developed any cancer, or were lost to follow-up within 2 years. Final study populations for our analysis are summarized in Table 1.
Table 1. Characteristics of the Cohort Studies Included in the Pooled Analysis of Dietary Fat Intake and Lung Cancer

Dietary Assessment

Dietary information at baseline was assessed by using validated food frequency questionnaires or quantitative dietary questionnaires.28-38 Based on study-specific food composition tables, each study estimated daily intakes of total energy, carbohydrate, protein, and fat (ie, total, saturated, monounsaturated, and polyunsaturated fat).

Outcome Assessment

Incident cases of lung cancer were ascertained per each study protocol, via active and/or passive follow-up methods, including data linkage to cancer and death registries and self-reports confirmed by medical record review. Based on the International Classification of Diseases for Oncology, lung cancers were classified into five histologic types: adenocarcinoma, squamous cell carcinoma, other kinds of non-small cell carcinoma, small cell carcinoma, and others, including carcinoma not otherwise specified, sarcoma, and any kind of uncertain types.

Statistical Analysis

Hazard ratios (HRs) and 95% CIs were estimated in each cohort by fitting the Cox proportional hazards models. Proportional hazard assumption was tested using time-by-covariate interactions and no evidence of violation was found. All models were stratified by baseline age groups and enrollment years (both in 5-year intervals). Follow-up time was treated as the time scale, calculated as the total time from 730 days (2 years) after enrollment until the date of diagnosis of any cancer, date of death, end of follow-up, or follow-up loss, whichever came first. Intakes of macronutrients were analyzed as percentages of total energy intake.39 Dietary fat intakes were modeled as categorical variables using cohort- and sex-specific quintiles, with the lowest quintile as reference. Linear trend tests were conducted using the Wald test, with continuous values corresponding to the median value for each quintile. Risk estimates from each study were pooled based on their inverse variance weights. Heterogeneity across the studies was evaluated by the Q and I2 statistics.40-42 We adopted random-effects models if P for heterogeneity was < .10,42 or fixed-effect models when observing no evidence for heterogeneity.
Covariates were selected based on prior knowledge of putative risk factors for lung cancer and their associations with lung cancer risk in the current study. Included were age (continuous), sex, smoking status (never, former, current), smoking pack-years (continuous), family history of lung cancer, race/ethnicity (white, black, Asian, others), educational attainment (less than high school, high school graduate, vocational/professional education, college education, university graduate, graduate studies), alcohol consumption (0 g/d, > 0 to ≤ 28 g/d in men; or > 0 to ≤ 14 g/d in women; > 28 g/d in men; or > 14 g/d in women), physical activity (tertiles of leisure time or total activity measured by hours or metabolic equivalent hours), obesity status (body mass index [BMI] < 18.5, 18.5 to 24.9, 25 to 29.9, ≥ 30 kg/m2; results remained the same if Asian-specific BMI cutoff points were used for Asian population), total vegetable intake (cohort- and sex-specific quintiles), and menopausal status in women.
We conducted all analyses using multivariate nutrient-density models that included total energy intake, percentage of energy from fat, and all aforementioned covariates.39 To estimate the association for specific type of fat, saturated, monounsaturated, and polyunsaturated fats were mutually adjusted. The results can be interpreted as the substitution effects of energy from total or a particular type of fat for equivalent energy from carbohydrate and protein. Furthermore, to evaluate effect of a 5% energy substitution, we modeled specific fat intakes as continuous variables and estimated substitution effects by calculating the difference in the coefficients of the two targeted fats.43
In addition, we pooled individual data into a single dataset and conducted aggregated pooled-analyses. Interactions between fat and smoking status, sex, and race/ethnicity were evaluated by likelihood ratio test. Heterogeneity across histologic types of lung cancer was evaluated. Possible nonlinear relationship between dietary fat and lung cancer was evaluated with the restricted cubic spline regression. To reduce influences due to extreme values, participants with the highest 1% of each fat intake were excluded from the analysis. A series of sensitivity analyses was conducted, including using the residual method to adjust for total energy intake, using project-wide sex-specific quintiles instead of cohort- and sex-specific cutoffs, and further adjusting for red meat intake, a major food source of total and saturated fat as well as a putative lung cancer risk factor.44,45
Statistical analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC) and STATA 12 (StataCorp, College Station, TX). All P values were two sided and statistical significance was set at .05.

Results

Among a total of 1,445,850 participants (627,988 men and 817,862 women, after excluding the first 2 years of follow-up), 18,822 primary, incident lung cancer cases were identified over follow-up periods of 4.3 to 20.7 years. Mean intakes of total fat ranged from 15.5% to 34.9% of energy across studies. Substantially lower intakes of all types of fat were observed in Asian populations than those in the United States and European populations (Table 1; Appendix Table A1, online only).
At baseline, participants who reported a higher fat intake had a higher BMI and lower levels of education and physical activity (Table 2). Prevalence of current smoking and cumulative lifetime tobacco exposure was significantly higher among people with high fat intakes. All differences across total fat intake were statistically significant, and these patterns were consistently observed in men and women.
Table 2. Baseline Characteristics Across Quintiles of Total Fat Intake*
After adjusting for potential confounders, total and saturated fat showed significant associations with an increased risk of lung cancer (HR [95% CI] in the highest v lowest quintile, 1.07 [1.00 to 1.15] and 1.14 [1.07 to 1.22], respectively; P for trend for both < .001; Table 3). Conversely, polyunsaturated fat was associated with a decreased risk of lung cancer (HR [95% CI], 0.92 [0.87 to 0.98]; P for trend = .02). There was no evidence of heterogeneity across studies (Table 3; Appendix Fig A1, online only). When stratified by smoking status, significant associations were observed only among ever smokers (P for trend < .001 for total and saturated fat and P for trend = .03 for polyunsaturated fat). No associations were found for monounsaturated fat (Table 3).
Table 3. Risk of Lung Cancer by Quintiles of Total and Specific Types of Dietary Fat Intakes*
The association of saturated fat with lung cancer risk appeared stronger among current smokers (HR [95% CI], 1.23 [1.13 to 1.35]; P for trend < .001; Table 4) than former and never smokers (P for interaction = .004), and for squamous cell carcinoma and small cell carcinoma (HR [95% CI], 1.61 [1.38 to 1.88] and 1.40 [1.17 to 1.67], respectively; P for trend for both < .001) than other histologic types (P for heterogeneity < .001). This histologic-specific association pattern existed regardless of smoking status, although the point estimates among never smokers did not reach statistical significance. Stratified analyses on polyunsaturated fat and lung cancer did not show significant interactions except that the association seemed more evident among Asians (HR [95% CI], 0.80 [0.66 to 0.96]; P for trend = .03) than other races (P for interaction = .04; Appendix Table A2, online only).
Table 4. Risk of Lung Cancer by Quintiles of Saturated Fat Intake: Stratified Analysis
Restricted cubic spline analyses indicated linear associations of saturated fat (positive) and polyunsaturated fat (inverse) with lung cancer (Fig 1). Given the differential association between these two fats, we evaluated isocaloric substitution effects of saturated fat with polyunsaturated fat (Table 4). Every 5% energy substitution was associated with an overall 12% lower risk of lung cancer (95% CI, 0.84 to 0.93). The beneficial effect was primarily found among current smokers and former smokers (especially those who quit smoking ≤ 10 years before). Noticeably, a 5% energy substitution was associated with a 17% lower risk of squamous cell carcinoma (95% CI, 0.74 to 0.93) and a 16% lower risk of small cell carcinoma (95% CI, 0.73 to 0.95).
Fig 1. Dose-response relationship of (A, B) saturated fat and (C, D) polyunsaturated fat intakes with lung cancer risk. Solid line indicates the hazard ratio of lung cancer and dashed line indicates the 95% CIs. The 10th percentile of saturated/polyunsaturated fat intake was set as reference, and four knot positions were fitted at the 5th, 25th, 75th, and 95th percentiles. All models were stratified by cohort, baseline age group, and enrollment year, and were adjusted for age, sex, race/ethnicity, smoking status, smoking pack-years, family history of lung cancer, educational attainment, alcohol consumption, physical activity level, obesity status, intakes of total energy and vegetable, and menopausal status in women. Specific types of fat were mutually adjusted. The results indicate the risk of lung cancer when substituting energy from saturated or polyunsaturated fat for equivalent energy from carbohydrate and protein.
Results from aggregated analyses were basically the same as main results from meta-analyses (Appendix Table A3, online only). Sensitivity analyses using residual method to control for total energy intake or project-wide cutoffs for fat intakes or further adjustment for red meat intake also yielded similar results (Appendix Tables A4 to A6, online only).

Discussion

In this pooled analysis of 10 prospective cohort studies, we found that high intakes of total or saturated fat were associated with an increased risk of lung cancer, particularly for squamous cell and small cell carcinoma. Specifically, the highest quintile of saturated fat intake showed a 61% higher risk for squamous cell carcinoma and a 40% higher risk for small cell carcinoma, compared with the lowest quintile. In contrast, a high intake of polyunsaturated fat was associated with a decreased risk of lung cancer. Isocaloric replacement of saturated fat with polyunsaturated fat (5% of energy) was associated with an overall 12% lower risk of lung cancer. Monounsaturated fat was not associated with lung cancer risk. Results did not change with the use of alternative analytic approaches and in a series of sensitivity analyses.
Despite controversy, saturated fat has been suggested to play an adverse role in the development of various cancers, including lung cancer.11,12,46-49 Significant positive association of saturated fat and lung cancer has been observed in case-control studies7-10 as well as in several, but not all, prospective studies.11-15 A previous pooled analysis of eight cohort studies among Western, predominantly white populations reported that a higher intake of saturated fat was associated with lung cancer risk in age-adjusted model (relative risk [RR] 1.21; 95% CI, 1.08 to 1.36 per 5% energy increase),14 although the association was attenuated after adjusting for lifestyle factors and smoking history. Previous studies have also suggested that the association between saturated fat intake and lung cancer may be more evident among smokers,11,12 especially male smokers and heavy smokers. In the current study, we found a significant interaction between smoking status and saturated fat intake in relation to lung cancer risk. The positive association of saturated fat and the beneficial association of substituting saturated with polyunsaturated fats were primarily seen among current smokers and former smokers who quit ≤ 10 years before. Although the underlying mechanisms remain largely unknown, potential biologic interaction between saturated fat and smoking was supported by animal studies. Nicotine-derived nitrosamine ketone (NNK) is a potent tobacco carcinogen.50 NNK promotes lung carcinogenesis by inducing cyclooxygenase-2, disrupting arachidonic acid signaling, and activating tumorigenic pathways.50 Noticeably, these tumor-promoting effects of NNK were found to be enhanced by a high-fat diet.51,52 Moreover, emerging evidence indicates that saturated fat itself may increase carcinogenesis by regulating DNA damage and inflammatory responses.53,54
In our study, we found that saturated fat was primarily associated with an increased risk of squamous cell and small cell carcinoma. Overall, the highest quintile of saturated fat intake exhibited a 40% to 61% higher risk. This histologic-specific pattern was also observed among never smokers, although the point estimates did not reach statistical significance. The nonsignificant association among never smokers might be due to a small number of cases for histologic type-specific analyses. Indeed, analyses without excluding the first 2 years of follow-up showed significant associations of saturated fat with squamous cell carcinoma (HR, 2.18; 95% CI, 1.06 to 4.47; P for trend = .04) and small cell carcinoma (HR, 2.36; 95% CI, 0.94 to 5.93; P for trend = .005) among never smokers. This finding is in line with one previous report,10 but in contrast with two case-control studies that reported the positive association of saturated fat appeared stronger for adenocarcinoma.7,8 Considering that smoking is more strongly associated with squamous cell and small cell carcinoma than other histologic types (ie, adenocarcinoma and large cell carcinoma),55 it is plausible that the adverse effects of saturated fat may be more pronounced for these histologic types of lung cancer. On the other hand, residual confounding from smoking could not be entirely excluded. Further studies are needed to examine the potential interplays between saturated fat intake, smoking, and different types of lung cancer, as well as the underlying biologic mechanisms.
Potential beneficial health effects of polyunsaturated fat have been widely discussed, but its association with lung cancer remains unclear. Previous cohort studies have yielded inconsistent but mostly null findings on the association between polyunsaturated fat and lung cancer.11-13,15 One study found a significant inverse association between a high intake of fat from plant foods, predominantly unsaturated fats, and lung cancer incidence (RR, 0.7; 95% CI, 0.5 to 0.9 for the highest v lowest quartile).15 The previously referenced pooled analysis14 found no association of polyunsaturated fat with lung cancer risk. A recent meta-analysis including eight prospective studies reported a nonsignificant, decreased lung cancer risk with high polyunsaturated fat intake (RR, 0.91; 95% CI, 0.78 to 1.06 for the highest v lowest category).17 Our current study, the largest study on this topic thus far, to our knowledge, showed polyunsaturated fat intake was inversely associated with lung cancer risk. We further found that substituting energy from saturated fat with polyunsaturated fat may reduce lung cancer risk. In vitro and in vivo studies have suggested several potential cancer inhibitory effects of polyunsaturated fat, especially n-3-polyunsaturated fat, including as an inhibitor for arachidonic acid and cyclooxygenase-2, an inflammatory mediator, and a suppressor of fatty acid synthase.6,51,56,57 N-3-polyunsaturated fat may also affect cytokine production and inflammatory gene expression.57 However, the role of n-6-polyunsaturated fat in carcinogenesis remains controversial. This study could not explore potential associations for specific polyunsaturated fats because of a lack of detailed information. Future studies focused on subtypes of polyunsaturated fat and their roles in the development of lung cancer are warranted.
As with other nutritional epidemiologic studies, measurement errors in dietary assessment are a concern, although the questionnaires used in participating cohorts have been validated and shown good validity.28-38 Furthermore, most participating cohorts have only collected dietary information at baseline and the single dietary assessment prohibited us from evaluating the influence of possible dietary changes over time. In the few cohorts that have conducted multiple dietary surveys, models using only baseline diet seemed to yield similar or weaker results compared with models using cumulative diet.58,59 Lack of information on subtypes of polyunsaturated fat is also a study limitation, as mentioned previously. We believe, however, that these potential measurement errors are nondifferential with respect to lung cancer status, given our prospective study design, and that our analytic strategies minimize the effect of potential bias on study results. The first 2 years of follow-up were excluded from analyses and cohort- and sex-specific cutoffs of dietary intakes were used to reduce the potential influences of reverse causation and varied dietary measures. All associations were evaluated with comprehensive adjustments for lung cancer risk factors, including smoking status and amount, dietary, and other nondietary factors, and results from sensitivity analyses were consistent with overall results. Nevertheless, we cannot rule out residual confounding by imperfectly measured covariates (eg, smoking) and unadjusted potential confounders (eg, trans-fat), nor could we distinguish the effect of fat from that of other nutrients and chemicals in fat-rich foods (eg, red meat) that may influence lung cancer risk. However, we have adjusted for total vegetable intake in our analysis, and the results did not change after further adjusting for red meat intake.
To our knowledge, this study is the largest prospective investigation on dietary fat intake and lung cancer risk to date, including six times as many cases as the previous pooled analysis14 and seven studies that have not been part of any previous pooled or meta-analyses. Moreover, our study includes diverse populations of whites, blacks, and Asians from three continents and provides evidence suggesting potentially different roles of saturated and polyunsaturated fats in the development of lung cancer.
In conclusion, findings from this large, international cohort consortium indicate that a high intake of saturated fat and a low intake of polyunsaturated fat are associated with an increased risk of lung cancer. Substituting saturated fat with polyunsaturated fat may reduce lung cancer risk, especially among smokers and for squamous cell and small cell carcinoma. Although the apparent benefit is relatively small compared with smoking avoidance and cessation, our study suggests that promoting polyunsaturated fat while reducing saturated fat intake, especially among current smokers and recent quitters, may present a modifiable dietary approach to the prevention of not only cardiovascular disease but also lung cancer.

Acknowledgment

We thank the staff and investigators of all participating cohorts for their dedicated efforts. We thank Nancy Kennedy for her assistance in editing and preparing the manuscript.
The National Cancer Institute had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.

Authors' Disclosures of Potential Conflicts of Interest

Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc.

Jae Jeong Yang

No relationship to disclose

Danxia Yu

No relationship to disclose

Yumie Takata

No relationship to disclose

Stephanie A. Smith-Warner

No relationship to disclose

William Blot

No relationship to disclose

Emily White

No relationship to disclose

Kim Robien

No relationship to disclose

Yikyung Park

No relationship to disclose

Yong-Bing Xiang

No relationship to disclose

Rashmi Sinha

No relationship to disclose

DeAnn Lazovich

No relationship to disclose

Meir Stampfer

No relationship to disclose

Rosario Tumino

No relationship to disclose

Dagfinn Aune

No relationship to disclose

Kim Overvad

No relationship to disclose

Linda Liao

No relationship to disclose

Xuehong Zhang

No relationship to disclose

Yu-Tang Gao

No relationship to disclose

Mattias Johansson

No relationship to disclose

Walter Willett

No relationship to disclose

Wei Zheng

No relationship to disclose

Xiao-Ou Shu

No relationship to disclose

Appendix

Fig A1. Risk of lung cancer associated with (A) saturated fat and (B) polyunsaturated fat intake (the highest v the lowest quintile) in each participating cohort. All models were adjusted for age, sex, smoking status, smoking pack-years, family history of lung cancer, race/ethnicity, educational attainment, alcohol consumption, physical activity level, obesity status, intakes of total energy and vegetable, and menopausal status in women. Specific types of fat were mutually adjusted. The results indicate the risk of lung cancer when substituting energy from saturated or polyunsaturated fat for equivalent energy from carbohydrate and protein. P for heterogeneity across studies = .38 for saturated fat and .33 for polyunsaturated fat. Abbreviations: AARP, National Institutes of Health-AARP Study (NIH-AARP); %E, percent energy; EPIC, European Prospective Investigation into Cancer & Nutrition; HPFS, Health Professionals’ Follow-up Study; IWHS, Iowa Women’s Health Study; NHS, Nurses' Health Study; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; SCCS, Southern Community Cohort Study; SHS, Shanghai Men's and Women's Health Studies; VITAL, Vitamins and Lifestyle Study.
Table A1. Dietary Fat Intake in the Participating Cohort Studies
Table A2. Risk of Lung Cancer by Quintiles of Polyunsaturated Fat Intake: Stratified Analysis
Table A3. Aggregated Pooled Analyses: Association of Lung Cancer With Total and Specific Types of Dietary Fat Intakes*
Table A4. Sensitivity Analysis Using the Residual Method for Energy Adjustment*
Table A5. Sensitivity Analysis Using the Same Sex-Specific Quintile Cut Points for All Cohorts*
Table A6. Sensitivity Analysis Further Adjusting for Red Meat Intake*

References

1.
Ferlay J, Soerjomataram I, Dikshit R, et al: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359-E386, 2015
2.
National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General [Internet]. Atlanta, GA, Centers for Disease Control and Prevention, 2014
3.
Sridhar MK: Nutrition and lung health. Proc Nutr Soc 58:303-308, 1999
4.
American Institute for Cancer Research, World Cancer Research Fund, (ed). Food, nutrition, physical activity and the prevention of cancer: A global perspective: A project of World Cancer Research Fund International. Washington, DC, American Institute for Cancer Research, 2007
5.
Vieira AR, Abar L, Vingeliene S, et al: Fruits, vegetables and lung cancer risk: A systematic review and meta-analysis. Ann Oncol 27:81-96, 2016
6.
Chen YQ, Edwards IJ, Kridel SJ, et al: Dietary fat-gene interactions in cancer. Cancer Metastasis Rev 26:535-551, 2007
7.
Alavanja MC, Brown CC, Swanson C, et al: Saturated fat intake and lung cancer risk among nonsmoking women in Missouri. J Natl Cancer Inst 85:1906-1916, 1993
8.
De Stefani E, Brennan P, Boffetta P, et al: Diet and adenocarcinoma of the lung: A case-control study in Uruguay. Lung Cancer 35:43-51, 2002
9.
Alavanja MC, Brownson RC, Benichou J: Estimating the effect of dietary fat on the risk of lung cancer in nonsmoking women. Lung Cancer 14:S63-S74, 1996 (suppl 1)
10.
Goodman MT, Kolonel LN, Yoshizawa CN, et al: The effect of dietary cholesterol and fat on the risk of lung cancer in Hawaii. Am J Epidemiol 128:1241-1255, 1988
11.
Bandera EV, Freudenheim JL, Marshall JR, et al: Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Causes Control 8:828-840, 1997
12.
Knekt P, Seppänen R, Järvinen R, et al: Dietary cholesterol, fatty acids, and the risk of lung cancer among men. Nutr Cancer 16:267-275, 1991
13.
Veierød MB, Laake P, Thelle DS: Dietary fat intake and risk of lung cancer: A prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 6:540-549, 1997
14.
Smith-Warner SA, Ritz J, Hunter DJ, et al: Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 11:987-992, 2002
15.
Wu Y, Zheng W, Sellers TA, et al: Dietary cholesterol, fat, and lung cancer incidence among older women: The Iowa Women’s Health Study (United States). Cancer Causes Control 5:395-400, 1994
16.
Song J, Su H, Wang B-L, et al: Fish consumption and lung cancer risk: Systematic review and meta-analysis. Nutr Cancer 66:539-549, 2014
17.
Zhang Y-F, Lu J, Yu F-F, et al: Polyunsaturated fatty acid intake and risk of lung cancer: A meta-analysis of prospective studies. PLoS One 9:e99637, 2014
18.
Schatzkin A, Subar AF, Thompson FE, et al: Design and serendipity in establishing a large cohort with wide dietary intake distributions : The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154:1119-1125, 2001
19.
Michaud DS, Liu Y, Meyer M, et al: Periodontal disease, tooth loss, and cancer risk in male health professionals: A prospective cohort study. Lancet Oncol 9:550-558, 2008
20.
Sinner P, Folsom AR, Harnack L, et al: The association of physical activity with lung cancer incidence in a cohort of older women: The Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev 15:2359-2363, 2006
21.
Baik CS, Strauss GM, Speizer FE, et al: Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses’ Health Study. Cancer Epidemiol Biomarkers Prev 19:2525-2533, 2010
22.
Zhu CS, Pinsky PF, Kramer BS, et al: The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst 105:1684-1693, 2013
23.
Signorello LB, Hargreaves MK, Steinwandel MD, et al: Southern community cohort study: Establishing a cohort to investigate health disparities. J Natl Med Assoc 97:972-979, 2005
24.
White E, Patterson RE, Kristal AR, et al: VITamins And Lifestyle cohort study: Study design and characteristics of supplement users. Am J Epidemiol 159:83-93, 2004
25.
Riboli E, Kaaks R: The EPIC Project: Rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26:S6-S14, 1997 (suppl 1)
26.
Shu X-O, Li H, Yang G, et al: Cohort profile: The Shanghai Men’s Health Study. Int J Epidemiol 44:810-818, 2015
27.
Zheng W, Chow W-H, Yang G, et al: The Shanghai Women’s Health Study: Rationale, study design, and baseline characteristics. Am J Epidemiol 162:1123-1131, 2005
28.
Thompson FE, Kipnis V, Midthune D, et al: Performance of a food-frequency questionnaire in the US NIH-AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr 11:183-195, 2008
29.
Rimm EB, Giovannucci EL, Stampfer MJ, et al: Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135:1114-1126, discussion 1127-1136, 1992
30.
Munger RG, Folsom AR, Kushi LH, et al: Dietary assessment of older Iowa women with a food frequency questionnaire: Nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews. Am J Epidemiol 136:192-200, 1992
31.
Willett WC, Sampson L, Stampfer MJ, et al: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65, 1985
32.
Subar AF, Thompson FE, Kipnis V, et al: Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : The Eating at America’s Table Study. Am J Epidemiol 154:1089-1099, 2001
33.
Signorello LB, Munro HM, Buchowski MS, et al: Estimating nutrient intake from a food frequency questionnaire: Incorporating the elements of race and geographic region. Am J Epidemiol 170:104-111, 2009
34.
Tsubono Y, Kobayashi M, Sasaki S, et al: Validity and reproducibility of a self-administered food frequency questionnaire used in the baseline survey of the JPHC Study Cohort I. J Epidemiol 13:S125-S133, 2003 (suppl 1)
35.
Ishihara J, Sobue T, Yamamoto S, et al: Validity and reproducibility of a self-administered food frequency questionnaire in the JPHC Study Cohort II: Study design, participant profile and results in comparison with Cohort I. J Epidemiol 13:S134-S147, 2003 (suppl 1)
36.
Villegas R, Yang G, Liu D, et al: Validity and reproducibility of the food-frequency questionnaire used in the Shanghai men’s health study. Br J Nutr 97:993-1000, 2007
37.
Shu XO, Yang G, Jin F, et al: Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women’s Health Study. Eur J Clin Nutr 58:17-23, 2004
38.
Slimani N, Ferrari P, Ocké M, et al: Standardization of the 24-hour diet recall calibration method used in the European Prospective Investigation Into Cancer and Nutrition (EPIC): General concepts and preliminary results. Eur J Clin Nutr 54:900-917, 2000
39.
Willett WC, Howe GR, Kushi LH: Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65:1220S-1228S; discussion 1229S-1231S, 1997 (suppl 4)
40.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
41.
Higgins JPT, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 327:557-560, 2003
42.
Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.handbook.cochrane.org.
43.
Smith-Warner SA, Spiegelman D, Adami HO, et al: Types of dietary fat and breast cancer: A pooled analysis of cohort studies. Int J Cancer 92:767-774, 2001
44.
Tasevska N, Sinha R, Kipnis V, et al: A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 89:1884-1894, 2009
45.
Alavanja MC, Field RW, Sinha R, et al: Lung cancer risk and red meat consumption among Iowa women. Lung Cancer 34:37-46, 2001
46.
Thiébaut ACM, Kipnis V, Chang S-C, et al: Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 99:451-462, 2007
47.
Freedman ND, Cross AJ, McGlynn KA, et al: Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst 102:1354-1365, 2010
48.
Sieri S, Krogh V, Ferrari P, et al: Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88:1304-1312, 2008
49.
Thiébaut ACM, Jiao L, Silverman DT, et al: Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst 101:1001-1011, 2009
50.
Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91:1194-1210, 1999
51.
Schuller HM: Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2:455-463, 2002
52.
El-Bayoumy K, Iatropoulos M, Amin S, et al: Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: The impact of a high-fat diet. Cancer Res 59:1400-1403, 1999
53.
Zeng L, Wu G-Z, Goh KJ, et al: Saturated fatty acids modulate cell response to DNA damage: Implication for their role in tumorigenesis. PLoS One 3:e2329, 2008
54.
Rocha DM, Caldas AP, Oliveira LL, et al: Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis 244:211-215, 2016
55.
Khuder SA: Effect of cigarette smoking on major histological types of lung cancer: A meta-analysis. Lung Cancer 31:139-148, 2001
56.
Azrad M, Turgeon C, Demark-Wahnefried W: Current evidence linking polyunsaturated fatty acids with cancer risk and progression. Front Oncol 3:224, 2013
57.
Calder PC: Dietary modification of inflammation with lipids. Proc Nutr Soc 61:345-358, 2002
58.
Fung TT, van Dam RM, Hankinson SE, et al: Low-carbohydrate diets and all-cause and cause-specific mortality: Two cohort studies. Ann Intern Med 153:289-298, 2010
59.
Pan A, Sun Q, Bernstein AM, et al: Red meat consumption and mortality: Results from 2 prospective cohort studies. Arch Intern Med 172:555-563, 2012

Information & Authors

Information

Published In

Journal of Clinical Oncology
Pages: 3055 - 3064
PubMed: 28742456

History

Published online: July 25, 2017
Published in print: September 10, 2017

Permissions

Request permissions for this article.

Authors

Affiliations

Jae Jeong Yang
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Danxia Yu [email protected]
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Yumie Takata
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Stephanie A. Smith-Warner
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
William Blot
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Emily White
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Kim Robien
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Yikyung Park
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Yong-Bing Xiang
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Rashmi Sinha
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
DeAnn Lazovich
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Meir Stampfer
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Rosario Tumino
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Dagfinn Aune
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Kim Overvad
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Linda Liao
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Xuehong Zhang
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Yu-Tang Gao
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Mattias Johansson
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Walter Willett
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Wei Zheng
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France
Xiao-Ou Shu
Jae Jeong Yang, Danxia Yu, Yumie Takata, William Blot, Wei Zheng, and Xiao-Ou Shu, Vanderbilt University Medical Center, Nashville, TN; Yumie Takata, Oregon State University, Corvallis, OR; Stephanie A. Smith-Warner, Meir Stampfer, and Walter Willett, Harvard T.H. Chan School of Public Health, Boston, MA; Emily White, Fred Hutchinson Cancer Research Center, Seattle, WA; Kim Robien, George Washington University, Washington, DC; Yikyung Park, Washington University School of Medicine, St Louis, MO; Yong-Bing Xiang and Yu-Tang Gao, Shanghai Jiaotong University School of Medicine, Shanghai, People’s Republic of China; Rashmi Sinha and Linda Liao, National Cancer Institute, Bethesda, MD; DeAnn Lazovich, University of Minnesota, Minneapolis, MN; Rosario Tumino, “Civic – M.P. Arezzo” Hospital, ASP Ragusa, Italy; Dagfinn Aune, Imperial College, London, United Kingdom; Kim Overvad, Aarhus University, Aarhus, Denmark; Xuehong Zhang, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA; Mattias Johansson, International Agency for Research on Cancer, Lyons, France

Notes

Corresponding author: Danxia Yu, PhD, Vanderbilt Epidemiology Center, 2525 West End Ave, Nashville, TN 37203; e-mail: [email protected].

Author Contributions

Conception and design: Jae Jeong Yang, Danxia Yu, Yumie Takata, Xiao-Ou Shu
Financial support: Yumie Takata, Xiao-Ou Shu
Administrative support: Xiao-Ou Shu
Collection and assembly of data: Jae Jeong Yang, Danxia Yu, Yumie Takata, Stephanie A. Smith-Warner, William Blot, Emily White, Kim Robien, Yikyung Park, Yong-Bing Xiang, Rashmi Sinha, DeAnn Lazovich, Meir Stampfer, Rosario Tumino, Kim Overvad, Linda Liao, Xuehong Zhang, Yu-Tang Gao, Mattias Johansson, Walter Willett, Wei Zheng, Xiao-Ou Shu
Data analysis and interpretation: Jae Jeong Yang, Danxia Yu, Stephanie A. Smith-Warner, William Blot, Emily White, Kim Robien, Yikyung Park, Yong-Bing Xiang, Rashmi Sinha, DeAnn Lazovich, Meir Stampfer, Dagfinn Aune, Kim Overvad, Linda Liao, Xuehong Zhang, Yu-Tang Gao, Mattias Johansson, Walter Willett, Wei Zheng, Xiao-Ou Shu
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors

Funding Information

Funded by Grant No. R03 CA183021 from the National Cancer Institute to X.-O.S. and Y.T.

Metrics & Citations

Metrics

Altmetric

Citations

Article Citation

Download Citation

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Jae Jeong Yang, Danxia Yu, Yumie Takata, Stephanie A. Smith-Warner, William Blot, Emily White, Kim Robien, Yikyung Park, Yong-Bing Xiang, Rashmi Sinha, DeAnn Lazovich, Meir Stampfer, Rosario Tumino, Dagfinn Aune, Kim Overvad, Linda Liao, Xuehong Zhang, Yu-Tang Gao, Mattias Johansson, Walter Willett, Wei Zheng, Xiao-Ou Shu
Journal of Clinical Oncology 2017 35:26, 3055-3064

View Options

View options

PDF

View PDF

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login

Purchase Options

Purchase this article to get full access to it.

Purchase this Article

Subscribe

Subscribe to this Journal
Renew Your Subscription
Become a Member

Media

Figures

Other

Tables

Share

Share

Share article link

Share